年龄相关性黄斑变性的新疗法。 - Suppr

Suppr

超能文献

New treatments for age-related macular degeneration.

作者信息

Imrie Fraser R, Bailey Clare

机构信息

Bristol Eye Hospital, Lower Maudlin Street, Bristol, BS1 2LX, UK.

出版信息

Age Ageing. 2007 Jan;36(1):8-10. doi: 10.1093/ageing/afl135.

DOI:10.1093/ageing/afl135

PMID:17264135

Abstract

摘要

相似文献

New treatments for age-related macular degeneration.

Age Ageing. 2007 Jan;36(1):8-10. doi: 10.1093/ageing/afl135.

Re: Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.

Retina. 2010 Feb;30(2):380; author reply 380-1. doi: 10.1097/IAE.0b013e3181c771d4.

Pegaptanib for wet macular degeneration.

Drugs Today (Barc). 2005 Nov;41(11):703-9. doi: 10.1358/dot.2005.41.11.917340.

Med Sci (Paris). 2007 Feb;23(2):127-9. doi: 10.1051/medsci/2007232127.

Antiangiogenic therapy in neovascular age-related macular degeneration.

Int Ophthalmol Clin. 2007 Winter;47(1):117-37. doi: 10.1097/IIO.0b013e31802bd873.

[Treatment of neovascular age-related macular degeneration with bevacizumab].

Farm Hosp. 2006 Nov-Dec;30(6):387-8. doi: 10.1016/s1130-6343(06)74013-2.

[VEGF inhibitors in ophthalmology].

Rev Med Liege. 2009 May-Jun;64(5-6):323-6.

[Antiangiogenic therapy].

Arch Soc Esp Oftalmol. 2005 Aug;80(8):435-6. doi: 10.4321/s0365-66912005000800001.

Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies.

Ophthalmology. 2009 Feb;116(2):286-96. doi: 10.1016/j.ophtha.2008.09.014. Epub 2008 Dec 16.

Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.

Retina. 2009 Feb;29(2):133-48. doi: 10.1097/IAE.0b013e3181960a28.

引用本文的文献

The EFFEct of HESA-A (natural drug) on visual acuity in age related macular degeneration: a randomized double blind controlled clinical trial.

Afr J Tradit Complement Altern Med. 2009 Jul 3;6(4):549-53. doi: 10.4314/ajtcam.v6i4.57199.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

New treatments for age-related macular degeneration.

Age Ageing. 2007 Jan;36(1):8-10. doi: 10.1093/ageing/afl135.

Re: Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.

Retina. 2010 Feb;30(2):380; author reply 380-1. doi: 10.1097/IAE.0b013e3181c771d4.

Pegaptanib for wet macular degeneration.

Drugs Today (Barc). 2005 Nov;41(11):703-9. doi: 10.1358/dot.2005.41.11.917340.

Med Sci (Paris). 2007 Feb;23(2):127-9. doi: 10.1051/medsci/2007232127.

Antiangiogenic therapy in neovascular age-related macular degeneration.

Int Ophthalmol Clin. 2007 Winter;47(1):117-37. doi: 10.1097/IIO.0b013e31802bd873.

[Treatment of neovascular age-related macular degeneration with bevacizumab].

Farm Hosp. 2006 Nov-Dec;30(6):387-8. doi: 10.1016/s1130-6343(06)74013-2.

[VEGF inhibitors in ophthalmology].

Rev Med Liege. 2009 May-Jun;64(5-6):323-6.

[Antiangiogenic therapy].

Arch Soc Esp Oftalmol. 2005 Aug;80(8):435-6. doi: 10.4321/s0365-66912005000800001.

Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies.

Ophthalmology. 2009 Feb;116(2):286-96. doi: 10.1016/j.ophtha.2008.09.014. Epub 2008 Dec 16.

Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.

Retina. 2009 Feb;29(2):133-48. doi: 10.1097/IAE.0b013e3181960a28.

引用本文的文献

The EFFEct of HESA-A (natural drug) on visual acuity in age related macular degeneration: a randomized double blind controlled clinical trial.

Afr J Tradit Complement Altern Med. 2009 Jul 3;6(4):549-53. doi: 10.4314/ajtcam.v6i4.57199.